Related Experiment Video
Updated: Aug 1, 2026
Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
Published on: December 15, 2010
Liposomal Nanomaterials: A Rising Star in Glioma Treatment
Yu Gan1,2, Yingying Yu1, Huizhe Xu2
1Department of Neurosurgery, Cancer Hospital of China Medical University, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning Province, People's Republic of China.
Abstract:
Glioma is a primary malignant tumor in the central nervous system. In recent years, the treatment of glioma has developed rapidly, but the overall survival of glioma patients has not significantly improved. Due to the presence of the blood-brain barrier and intracranial tumor barrier, many drugs with good effects to cure glioma in vitro cannot be accurately transported to the corresponding lesions. In order to enable anti-tumor drugs to overcome the barriers and target glioma, nanodrug delivery systems have emerged recently. It is gratifying that liposomes, as a multifunctional nanodrug delivery carrier, which can be compatible with hydrophilic and hydrophobic drugs, easily functionalized by various targeted ligands, biodegradable, and hypoimmunogenic in vivo, has become a quality choice to solve the intractable problem of glioma medication. Therefore, we focused on the liposome nanodrug delivery system, and summarized its current research progress in glioma. Hopefully, this review may provide new ideas for the research and development of liposome-based nanomaterials for the clinical treatment of glioma.
Insights
Liposomes offer a promising nanodrug delivery system to overcome the blood-brain barrier for effective glioma treatment. This review explores liposome advancements for targeting brain tumors and improving patient outcomes.
Area of Science:
- Neuro-oncology
- Nanotechnology
- Drug Delivery Systems
Background:
- Glioma remains a significant challenge in neuro-oncology, with limited therapeutic improvements despite advancements.
- The blood-brain barrier and intracranial tumor barriers impede effective drug delivery to glioma sites.
- Existing treatments struggle to deliver therapeutic agents efficiently to brain tumors.
Purpose of the Study:
- To review the current research progress of liposome nanodrug delivery systems in glioma treatment.
- To highlight the potential of liposomes in overcoming drug delivery challenges in the central nervous system.
- To provide insights for developing novel liposome-based nanomaterials for clinical glioma therapy.
Main Methods:
- Literature review focusing on liposome applications in glioma research.
- Analysis of liposome characteristics relevant to drug delivery across biological barriers.
- Synthesis of current findings on liposome-based glioma treatment strategies.
Main Results:
- Liposomes demonstrate versatility as nanocarriers for both hydrophilic and hydrophobic anti-glioma drugs.
- Liposomes can be functionalized with targeted ligands to enhance specificity for glioma cells.
- Their biodegradable and hypoimmunogenic properties make them suitable for in vivo applications.
- Liposomes show potential in overcoming the blood-brain barrier and intracranial tumor barriers.
Conclusions:
- Liposome nanodrug delivery systems represent a promising strategy for enhancing glioma treatment efficacy.
- Further research and development of liposome-based nanomaterials could lead to improved clinical outcomes for glioma patients.
- Liposomes offer a viable solution to the challenges of targeted drug delivery in brain tumors.
More Related Videos
07:25Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
Published on: March 1, 2024
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
